Screener
Rigel Pharmaceuticals RIGL Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
| Line item | As of / March 31, 2026 | As of / December 31, 2025 ⁽¹⁾ |
|---|---|---|
| Total current assets | 234,027 | 240,166 |
| Intangible assets, net | 24,160 | 24,748 |
| Deferred income tax asset | 243,279 | 245,852 |
| Operating lease right-of-use assets | 785 | 920 |
| Other assets | 2,357 | 1,908 |
| Total assets | $504,608 | $513,594 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: |
Item 1. Financial Statements
FAQ
- What is Rigel Pharmaceuticals's operating lease ROU assets?
- Rigel Pharmaceuticals (RIGL) reported operating lease ROU assets of $785K in Q1 2026.
- How has Rigel Pharmaceuticals's operating lease ROU assets changed year-over-year?
- Rigel Pharmaceuticals's operating lease ROU assets decreased by 39.8% year-over-year, from $1.31M to $785K.
- What is the long-term trend for Rigel Pharmaceuticals's operating lease ROU assets?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's operating lease ROU assets has grown at a -44.8% compound annual growth rate (CAGR), from $17.9M to $920K.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Rigel Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude